QTRX - Quanterix Corp
IEX Last Trade
13.05
-0.190 -1.456%
Share volume: 287,848
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$13.24
-0.19
-1.44%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-08 | 2022-11-09 | 2023-03-06 | 2023-05-09 | 2023-08-08 | 2023-11-08 | 2024-02-29 | 2024-05-08 | |
Assets | |||||||||
Total Assets | 488.601 M | 446.697 M | 434.199 M | 427.313 M | 429.210 M | 429.042 M | 425.011 M | 411.749 M | |
Current Assets | 413.198 M | 386.784 M | 381.403 M | 375.972 M | 379.058 M | 381.011 M | 378.394 M | 366.763 M | |
Inventories | 21.985 M | 18.236 M | 16.786 M | 17.070 M | 18.156 M | 19.945 M | 22.365 M | 26.015 M | |
Other Current Assets | 10.237 M | 6.475 M | 6.860 M | 7.002 M | 6.954 M | 9.273 M | 156.193 M | 9.551 M | |
Short Term Investments | 10.237 M | 6.475 M | 6.860 M | 7.002 M | 6.954 M | 9.273 M | 156.193 M | 9.551 M | |
Total Receivables | 19.683 M | 18.330 M | 19.017 M | 22.546 M | 24.423 M | 24.083 M | 25.414 M | 29.276 M | |
Current Cash | 361.293 M | 343.743 M | 338.740 M | 329.354 M | 329.525 M | 327.710 M | 174.422 M | 301.921 M | |
Total Non-current Assets | 75.403 M | 59.913 M | 52.796 M | 51.341 M | 50.152 M | 48.031 M | 46.617 M | 44.986 M | |
Property Plant Equipment | 22.295 M | 21.441 M | 20.162 M | 19.056 M | 18.328 M | 17.517 M | 17.926 M | 17.492 M | |
Other Assets | 377.000 K | 1.200 M | 1.298 M | 1.345 M | 2.282 M | 2.004 M | 1.802 M | 1.802 M | |
Intangible Assets | 8.527 M | 7.511 M | 7.516 M | 7.129 M | 6.476 M | 6.003 M | 6.034 M | 5.339 M | |
Goodwill | 8.675 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 488.601 M | 446.697 M | 434.199 M | 427.313 M | 429.210 M | 429.042 M | 425.011 M | 411.749 M | |
Total liabilities | 83.145 M | 73.928 M | 75.259 M | 69.981 M | 73.854 M | 75.690 M | 78.084 M | 70.311 M | |
Total current liabilities | 36.669 M | 28.571 M | 30.958 M | 26.937 M | 31.947 M | 35.153 M | 38.457 M | 32.241 M | |
Accounts Payable | 5.983 M | 2.106 M | 3.836 M | 2.585 M | 3.238 M | 4.786 M | 5.048 M | 3.914 M | |
Other liabilities | 3.341 M | 3.161 M | 2.884 M | 2.635 M | 2.529 M | 2.231 M | 2.404 M | 1.986 M | |
Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other liabilities | 3.341 M | 3.161 M | 2.884 M | 2.635 M | 2.529 M | 2.231 M | 2.404 M | 1.986 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 405.456 M | 372.769 M | 358.940 M | 357.332 M | 355.356 M | 353.352 M | 346.927 M | 341.438 M | |
Common stock | 36.922 M | 37.005 M | 37.186 M | 37.327 M | 37.494 M | 37.657 M | 37.898 M | 38.126 M | |
Retained earnings | -348.517 M | -383.581 M | -402.162 M | -408.265 M | -414.329 M | -422.087 M | -434.496 M | -444.568 M |